"10.1371_journal.pone.0121977","plos one","2015-03-30T00:00:00Z","Lily L Wong; Quentin N Pye; Lijuan Chen; Sudipta Seal; James F McGinnis","Department of Ophthalmology, University of Oklahoma Health Sciences Center, College of Medicine, and Dean McGee Eye Institute, Oklahoma City, Oklahoma, United States of America; Advanced Materials Processing Analysis Center, Materials Science and Engineering, Nanoscience and Technology Center, College of Medicine, University of Central Florida, Orlando, Florida, United States of America; Department of Cell Biology and Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Graduate College, Oklahoma City, Oklahoma, United States of America","Conceived and designed the experiments: LLW JFM. Performed the experiments: LLW QNP LC. Analyzed the data: LLW QNP LC. Contributed reagents/materials/analysis tools: SS. Wrote the paper: LLW QNP LC SS JFM.","LLW, SS, and JFM are co-inventors of US Patents: 7,727,559 (Inhibition of reactive oxygen species and protection of mammalian cells),7,347,987 (Inhibition of reactive oxygen species and protection of mammalian cells), and 8,703,200 (Inhibition of neovascularization by cerium oxide nanoparticles), and European Patent: 1,879,570 (Inhibition of reactive oxygen species and protection of mammalian cells), and Australian Patent: 2,006,242,541 (Inhibition of reactive oxygen species and protection of mammalian cells). SS is a coinventor of US Patent: 7,504,356 (Nanoparticles of cerium oxide having superoxide dismutase activity). JFM is Chief Scientist of a startup company, Nantiox, which is licensed to use nanoceria to destroy reactive oxygen species but no corporate funding was used to support this research. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2015","03","Lily L Wong","LLW",5,TRUE,2,3,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
